Get the Stockscreener App
10.53
1.86%
-0.22
Prothena Corporation Plc stock is traded at $10.53, with a volume of 349.61K.
It is down -1.86% in the last 24 hours and up +6.35% over the past month.
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
See More
Previous Close:
$10.75
Open:
$10.755
24h Volume:
349.61K
Relative Volume:
0.41
Market Cap:
$567.37M
Revenue:
$217.25M
Net Income/Loss:
$-50.92M
P/E Ratio:
-10.53
EPS:
-1
Net Cash Flow:
$-100.85M
1W Performance:
+1.74%
1M Performance:
+6.35%
6M Performance:
+24.12%
1Y Performance:
-36.64%
1-Day Range:
$10.40
$11.17
1-Week Range:
$10.34
$11.69
52-Week Range:
$4.32
$18.77
Prothena Corporation Plc Stock (PRTA) Company Profile
Name
Prothena Corporation Plc
Sector
Industry
Phone
011-353-1-236-2500
Address
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Compare PRTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
10.54 | 578.67M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.62 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.93 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.49 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
823.27 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.13 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Downgrade | BofA Securities | Neutral → Underperform |
| May-27-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-27-25 | Downgrade | Jefferies | Buy → Hold |
| May-27-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Jan-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Apr-24-23 | Initiated | SVB Securities | Outperform |
| Jan-27-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-28-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Jun-18-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-08-21 | Reiterated | Oppenheimer | Outperform |
| May-26-21 | Initiated | Citigroup | Buy |
| Feb-26-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-12-21 | Upgrade | Jefferies | Hold → Buy |
| Feb-02-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-20 | Initiated | H.C. Wainwright | Buy |
| Jul-09-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-19-19 | Upgrade | Evercore ISI | In-line → Outperform |
| May-21-18 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-23-18 | Downgrade | Jefferies | Buy → Hold |
| Apr-05-18 | Reiterated | Barclays | Overweight |
| Nov-20-17 | Downgrade | Wedbush | Outperform → Neutral |
| Sep-29-17 | Reiterated | BTIG Research | Buy |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Aug-17-17 | Initiated | Evercore ISI | Outperform |
| Jul-11-17 | Initiated | Jefferies | Buy |
| Apr-12-17 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-12-17 | Initiated | Piper Jaffray | Overweight |
| Mar-02-17 | Initiated | Instinet | Buy |
| Dec-21-16 | Initiated | SunTrust | Buy |
| Nov-03-16 | Initiated | Deutsche Bank | Buy |
| Aug-04-16 | Reiterated | Barclays | Overweight |
| May-13-16 | Initiated | Barclays | Overweight |
| Feb-19-16 | Reiterated | Wedbush | Outperform |
| Jan-21-16 | Initiated | Credit Suisse | Outperform |
View All
Prothena Corporation Plc Stock (PRTA) Latest News
Is this a good reentry point in Prothena Corporation plcAnalyst Downgrade & High Yield Stock Recommendations - newser.com
Should you hold or exit Prothena Corporation plc nowPortfolio Value Summary & Expert Verified Movement Alerts - newser.com
Should you wait for a breakout in Prothena Corporation plcPortfolio Value Summary & Short-Term Swing Trade Alerts - newser.com
Signal strength of Prothena Corporation plc stock in tech scannersInflation Watch & Fast Entry Momentum Alerts - newser.com
Will Prothena Corporation plc stock see insider buyingMarket Growth Report & Fast Moving Stock Trade Plans - newser.com
What MACD and RSI say about Prothena Corporation plc2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
How Prothena Corporation plc stock trades before earnings2025 Support & Resistance & Low Risk High Reward Trade Ideas - newser.com
What’s the recovery path for long term holders of Prothena Corporation plcQuarterly Risk Review & AI Optimized Trading Strategy Guides - newser.com
Using portfolio simulators with Prothena Corporation plc includedTrade Exit Report & Safe Capital Growth Plans - newser.com
Market reaction to Prothena Corporation plc’s recent newsWeekly Trade Summary & Real-Time Sentiment Analysis - newser.com
Risk vs reward if holding onto Prothena Corporation plcWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Prothena (PRTA) to Release Quarterly Earnings on Thursday - MarketBeat
Will Prothena Corporation plc stock recover faster than marketMarket Movement Recap & AI Enhanced Trading Signals - newser.com
What analysts say about Prothena Corporation plc stockFlag and Pennant Patterns & Accelerated Capital Growth - earlytimes.in
Will Prothena Corporation plc stock reach all time highs in 2025Take Profit & Technical Pattern Based Buy Signals - newser.com
Will Prothena Corporation plc stock see PE expansionJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - newser.com
Applying chart zones and confluence areas to Prothena Corporation plcJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
What to expect from Prothena Corporation plc in the next 30 daysWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
Prothena to Report Third Quarter 2025 Financial Results on November 6 - BioSpace
Prothena Corporation Plc Stock (PRTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Prothena Corporation Plc Stock (PRTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
| EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
| SCULLY WILLIAM P | 10% Owner |
Jan 14 '25 |
Buy |
12.79 |
100,000 |
1,279,040 |
735,993 |
| SCULLY WILLIAM P | 10% Owner |
Dec 18 '24 |
Buy |
13.93 |
73,436 |
1,022,670 |
1,297,693 |
| SCULLY WILLIAM P | 10% Owner |
Dec 31 '24 |
Buy |
13.01 |
32,000 |
416,393 |
650,193 |
| SCULLY WILLIAM P | 10% Owner |
Dec 20 '24 |
Buy |
15.91 |
2,000 |
31,813 |
618,693 |
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):